Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Choosing the right funds for a retirement portfolio requires balance of cost and coverage. Review 2024 options and practical selection tips.
26,319 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Aveanna Healthcare stock jumped 23%, but a major fund still sold $16 million of AVAH shares. This article breaks down...
TJX delivered a solid quarter, lifting confidence in a consumer-driven recovery. This analysis dives into whether com...
The trillion-dollar club has swelled to 14 as of late May 2026, led by AI-enabled tech giants. The combined market ca...
CoStar Group blends a high performing CRE data backbone with a slower moving homes marketplace. This piece breaks dow...
A fast-growing Brazilian fintech is reshaping personal finance in Latin America. Here are three concrete reasons this...
A new study shows a widening gap between the skills-based hiring mantra and its execution, as more than half of emplo...
Fox stock is down after announcing a Roku deal, leaving investors weighing value vs risk. This guide breaks down the ...
Cloud giants and AI pioneers are driving a wave of data-center investment. We break down three stock picks that could...
Investors weigh dividend safety check: aristocrats against the broad market as rates shift and AI-driven volatility f...
A hypothetical move where Paramount aligns with Warner Bros. Discovery would ripple through streaming, financing, and...
When headlines hint at a fallout between two A-list friends, the impact isn’t just gossip. This article digs into the...